[{"Assets_0_Q3_USD":111366000.0,"CommonStockSharesOutstanding_0_Q3_shares":8095120.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-10154000.0,"NetIncomeLoss_1_Q3_USD":-6880000.0,"NetIncomeLoss_3_Q3_USD":-20874000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":1576862.0,"StockholdersEquity_0_Q3_USD":93224000.0,"Ticker":"GEVO","CIK":"1392380","name":"GEVO, INC.","OfficialName":"Gevo Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"886730226.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20181106"}]